{
    "eid": "2-s2.0-85115883855",
    "title": "Associations of the srebf2 gene and insig2 polymorphisms with obesity and dyslipidemia in thai psychotic disorder patients treated with risperidone",
    "cover-date": "2021-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (miscellaneous)",
            "@code": "2701",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Dyslipidemia",
        "INSIG2 polymorphism",
        "Obesity",
        "Risperidone",
        "SREBF2 gene polymorphism"
    ],
    "authors": [
        "Natchaya Vanwong",
        "Chonlaphat Sukasem",
        "Weerapon Unaharassamee",
        "Napa Jiratjintana",
        "Chalitpon Na Nakorn",
        "Yaowaluck Hongkaew",
        "Apichaya Puangpetch"
    ],
    "citedby-count": 0,
    "ref-count": 40,
    "ref-list": [
        "Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: A critical review",
        "The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population",
        "Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences",
        "Metabolic Syndrome: Systems Thinking in Heart Disease",
        "Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic",
        "Comorbidities and mortality in persons with schizophrenia: A Swedish national cohort study",
        "Excess mortal-ity, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden",
        "Metabolic side effects of antipsychotic medication",
        "The impact of weight gain on quality of life among persons with schizophrenia",
        "Genetics of Common Antipsychotic-Induced Adverse Effects",
        "Progress in Genetic Polymorphisms Related to Lipid Disturbances Induced by Atypical Antipsychotic Drugs",
        "Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia",
        "Gene-gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics",
        "SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond",
        "SREBPs: Regulators of cholesterol/lipids as therapeutic targets in metabolic disorders, cancers and viral diseases",
        "Insulin-induced gene: A new regulator in lipid metabolism",
        "A potential mechanism underlying atypical antipsychotics-induced lipid disturbances",
        "Association study of SREBF-2 gene polymorphisms and the risk of type 2 diabetes in a sample of Iranian population",
        "Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of anti-psychotic-treated schizophrenic patients: Perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse ef-fects?",
        "A common genetic variant is associated with adult and childhood obesity",
        "Safety and tolerability: How do newer generation \u201catypical\u201d antipsychotics compare?",
        "Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review",
        "Cardiovascular disease in patients with schizophrenia",
        "Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database",
        "Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia",
        "A retrospective comparison of weight, lipid, and glucose changes between risperidone-and olanzapine-treated inpatients: Metabolic outcomes after 1 year",
        "Changes of Body Weight and Triglyceride Level in Schizophrenia Patients Treated with Atypical Antipsychotics",
        "SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver",
        "Expression of Sterol Regulatory Element-Binding Proteins in epicardial adipose tissue in patients with coronary artery disease and diabetes mellitus: Preliminary study",
        "Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins",
        "Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation",
        "Inte-grating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels",
        "A common polymorphism is associated with body mass index in Uyghur population",
        "Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes",
        "INSIG2 polymorphism is neither associated with BMI nor with phenotypes of lipoprotein metabolism",
        "Meta-Analysis of the INSIG2 Association with Obesity Including 74,345 Individuals: Does Heterogeneity of Esti-mates Relate to Study Design?",
        "Absence of association between the INSIG2 gene polymorphism (rs7566605) and obesity in the European Youth Heart Study (EYHS)",
        "Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients",
        "Association of Hypertriglyceridemia with All-Cause Mortality and Atherosclerotic Cardiovascular Events in a Low-Risk Italian Population: The TG-REAL Retrospective Cohort Analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "112681896",
            "affilname": "Somdet Chaopraya Institute of Psychiatry",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112681896",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Special Task Force for Activating Research",
        "Chulalongkorn University",
        "Mahidol University",
        "Faculty of Allied Health Sciences"
    ]
}